ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
ZIP1 Is a Critical DNA Damage-Responsive Zinc Transporter Induced by Bleomycin via the TNFα-NF-κB Pathway.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Zinc is an essential trace element that plays a significant role in DNA damage repair (DDR). Cells must maintain zinc homeostasis to effectively respond to DNA damage caused by various stressful stimuli. Members of the Zrt-, Irt-related protein (ZIP) family are recognized as key regulators of intracellular zinc levels. Dysfunction of ZIPs has been associated with numerous diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders. In the present study, human bronchial epithelial BEAS-2B cells were used to investigate the response of ZIPs to bleomycin, a well-known antibiotic that induces DNA damage. Among the ZIPs that exhibited altered expression following bleomycin treatment, ZIP1 showed the most prompt and significant induction. Both knockdown and overexpression experiments demonstrated that ZIP1 plays a crucial role in the cellular response to DNA damage. Mechanistically, we found that the level of TNFα was upregulated in bleomycin-treated cells, and inhibiting this cytokine reduced the induction effect of ZIP1 caused by bleomycin. Additionally, we observed an increase in the accumulation of NF-κB in the cell nuclei, and inhibition of NF-κB also diminished the effect of bleomycin on ZIP1. Two NF-κB binding sites were identified in the upstream sequence of SLC39A1, the gene that encodes ZIP1. The application of bleomycin significantly enhanced the binding of NF-κB to these specific sites. Taken together, our study reveals that bleomycin treatment may activate the TNFα-NF-κB pathway, which in turn upregulates ZIP1, helping cells better cope with the DNA damage induced by this antibiotic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.